EU

Eukedos SpAMIL Eukedos Stock Report

Last reporting period 30 Jun, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

0.121

Micro

Exchange

XMIL - Borsa Italiana S.P.A.

EUK.MI Stock Analysis

EU

Avoid

Based on Eyestock quantitative analysis, EUK.MI`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

32/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

24.6 %

Undervalued

Market cap $B

0.121

Dividend yield

Shares outstanding

22.742 B

Eukedos SpA specializes in the managed care and nursing home management sectors. The company is headquartered in Florence, Firenze and currently employs 760 full-time employees. The company went IPO on 2006-08-01. The company operates through four segments. The Care segment is focused on the management of retirement homes for elderly and adults disabled. The Medical Devices segment covers production and supply of products for infusion therapy and non-woven products to other customized products for the pharmaceutical industry. The Equipment segment includes the design, manufacturing and supply of machines for washing and sterilization for the pharmaceutical and hospital equipment, as well as cooking machines for the communities. The Contract segment covers the manufacturing and supplying turnkey furniture for hospitals, nursing homes, and communities in general. On June 2013, it sold a 70% stake in Teoreo Srl to Piofin Srl. In August 2013, it sold a 66.07% stake in San Nicola Srl for its subsidiary Edos SpA. In October 2013, it sold a 100% stake of its subsidiary Icos Impianti Group.

View Section: Eyestock Rating